CYH Community Health Systems (CYH) Insider Trading, Ownership & Congress Trades
Healthcare Services · Services-general medical & surgical hospitals, nec · CIK 0001108109
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
98
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $0 priced
What the filings say about CYH
Insiders, 180 days
-$118.4K net sold
1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$120.0K
1 notice
Community Health Systems insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, COMMUNITY HEALTH SYSTEMS INC insiders sold a net $118.4K of stock across 9 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 104.0% of the 38,468 shares held after it.
- No other insider sold within 30 days.
- 98 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director JENNINGS WILLIAM NORRIS sold about $118.4K of CYH on Aug 25, 2026, the largest insider sale at the company on our record; 98 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 43.4% of the 55,000 shares held after it.
- No other insider sold within 30 days.
- 98 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CMO BENET MIGUEL S sold about $84.3K of CYH on Feb 21, 2025, the largest insider sale at the company on our record; 98 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Aug 2, 2022.
- -2.3% median (-2.3% mean) 90-day return after 2 previous buys.
- The trade is 19.6% of the 5,107,901 shares held after it.
- No other insider bought within 30 days.
- 98 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SMITH WAYNE T bought about $2.1M of CYH on Oct 31, 2023, the largest insider purchase at the company since 2022; 98 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Aug 1, 2022.
- The trade is 19.7% of the 4,059,196 shares held after it.
- No other insider bought within 30 days.
- 98 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Chairman SMITH WAYNE T bought about $2.4M of CYH on Aug 2, 2022, the largest insider purchase at the company on our record; 98 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 6.1% of the 3,259,196 shares held after it.
- No other insider bought within 30 days.
- 98 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Chairman SMITH WAYNE T bought about $600.0K of CYH on Aug 1, 2022, the largest insider purchase at the company on our record; 98 funds added in the latest 13F quarter.9 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$118.4K over 180 days
-$118.4K over 90 days
more than 70% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
98 funds bought in last quarter
below 65% of Healthcare Services
Revenue
-1.2% year over year
below 78% of Healthcare Services
Margin
4.1% net margin
more than 67% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
14.9% of the float short (float per yahoo 2026-10-26) · 9.8 days to cover · settled 2026-09-30
more than 82% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CYH
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-9.6%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CYH: institutional holders (13F)
13F holdings, latest reported quarter
13,384,586 sh
$44.7M
11,859,526 sh
$39.6M
10,930,538 sh
$36.5M
7,864,575 sh
$26.3M
6,703,109 sh
$22.4M
Congress trades in CYH
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CYH planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
William Norris Jennings
Filed 2026-08-25
$120.0K
CYH mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$862.4K position · as of 2026-06-30
0.6%
Harbor AlphaEdge Small Cap Earners ETF
$53.6K position · as of 2026-07-31
0.4%
DoubleLine Fortune 500 Equal Weight ETF
$82.2K position · as of 2026-06-30
0.3%
NVIT GS Small Cap Equity Insights Fund
$214.1K position · as of 2026-06-30
0.1%
WisdomTree U.S. SmallCap Fund
$699.9K position · as of 2026-06-30
0.1%
iShares Micro-Cap ETF
$1.5M position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Wayne Smith
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2020
$9.1M
$10.6M
$3.7M
+156%
+14%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $118.4K sold by insiders over 180 days, 98 funds added last quarter, $120.0K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
CYH financials
Revenue growth
-1.2%
XBRL, annual
Net margin
4.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$12.0B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CYH
| FY Dec 2025 | $12.5B |
| FY Dec 2024 | $12.6B |
| FY Dec 2023 | $12.5B |
| FY Dec 2022 | $12.2B |
| FY Dec 2021 | $12.4B |
| Jun 2026 | $2.8B |
| Mar 2026 | $3.0B |
| Dec 2025 | $3.1B |
| Sep 2025 | $3.1B |
| Jun 2025 | $3.1B |
| Mar 2025 | $3.2B |
| Dec 2024 | $3.3B |
| Sep 2024 | $3.1B |
At each fiscal year end
Single quarter
Net margin, TTM
+2.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CYH
| FY Dec 2025 | +4.1% |
| FY Dec 2024 | -4.1% |
| FY Dec 2023 | -1.1% |
| FY Dec 2022 | +0.4% |
| FY Dec 2021 | +1.9% |
| Jun 2026 | +2.5% |
| Mar 2026 | -2.0% |
| Dec 2025 | +3.5% |
| Sep 2025 | +4.2% |
| Jun 2025 | +9.0% |
| Mar 2025 | -0.4% |
| Dec 2024 | -2.1% |
| Sep 2024 | -12.7% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$185.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CYH
| FY Dec 2025 | $208.0M |
| FY Dec 2024 | $120.0M |
| FY Dec 2023 | -$257.0M |
| FY Dec 2022 | -$115.0M |
| FY Dec 2021 | -$600.0M |
| Jun 2026 | $12.0M |
| Mar 2026 | -$373.0M |
| Dec 2025 | $172.0M |
| Sep 2025 | $4.0M |
| Jun 2025 | -$3.0M |
| Mar 2025 | $35.0M |
| Dec 2024 | $107.0M |
| Sep 2024 | -$3.0M |
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity CYH
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.01x
TTM operating cash flow over long-term 2026-06-30 plus current 2019-09-30 (82 months older than the period end)
Cash flow to debt CYH
| FY Dec 2025 | 0.05x |
| FY Dec 2024 | 0.04x |
| FY Dec 2023 | 0.02x |
| FY Dec 2022 | 0.03x |
| FY Dec 2021 | -0.01x |
| Jun 2026 | 0.01x |
| Mar 2026 | 0.01x |
| Dec 2025 | 0.05x |
| Sep 2025 | 0.05x |
| Jun 2025 | 0.04x |
| Mar 2025 | 0.04x |
| Dec 2024 | 0.04x |
| Sep 2024 | 0.03x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity CYH
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CYH
| FY Dec 2025 | +3.7% |
| FY Dec 2024 | -3.6% |
| FY Dec 2023 | -0.9% |
| FY Dec 2022 | +0.3% |
| FY Dec 2021 | +1.5% |
| Jun 2026 | +2.0% |
| Mar 2026 | +3.4% |
| Dec 2025 | +3.7% |
| Sep 2025 | +2.4% |
| Jun 2025 | -1.4% |
| Mar 2025 | -3.4% |
| Dec 2024 | -3.6% |
| Sep 2024 | -2.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+15.0%
operating income after a 11.4% effective tax rate, over long-term 2026-06-30 plus current 2019-09-30 (82 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital CYH
| FY Dec 2025 | +15.6% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | +15.0% |
| Mar 2026 | +15.8% |
| Dec 2025 | +15.6% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+12.7%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CYH
| FY Dec 2025 | +13.1% |
| FY Dec 2024 | +4.5% |
| FY Dec 2023 | +7.7% |
| FY Dec 2022 | +6.5% |
| FY Dec 2021 | +10.8% |
| Jun 2026 | +12.7% |
| Mar 2026 | +13.4% |
| Dec 2025 | +13.1% |
| Sep 2025 | +11.5% |
| Jun 2025 | +7.4% |
| Mar 2025 | +5.0% |
| Dec 2024 | +4.5% |
| Sep 2024 | +4.9% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
1.59x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CYH
| FY Dec 2025 | 0.83x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 12.00x |
| FY Dec 2021 | 7.65x |
| Jun 2026 | 1.82x |
| Mar 2026 | 0.86x |
| Dec 2025 | 0.83x |
| Sep 2025 | 1.32x |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$10.1B
market value at close 2026-10-23 on 2026-07-16 shares, plus long-term 2026-06-30 plus current 2019-09-30 (82 months older than the period end), minus cash 2026-06-30
Enterprise value CYH
| FY Dec 2025 | $10.9B |
| FY Dec 2024 | $12.1B |
| FY Dec 2023 | $12.2B |
| FY Dec 2022 | $12.4B |
| FY Dec 2021 | $13.7B |
| Jun 2026 | $10.2B |
| Mar 2026 | $10.1B |
| Dec 2025 | $10.9B |
| Sep 2025 | $11.2B |
| Jun 2025 | $11.2B |
| Mar 2025 | $11.6B |
| Dec 2024 | $12.1B |
| Sep 2024 | $12.6B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-44.9%
TTM free cash flow over market value at close 2026-10-23
FCF yield CYH
| FY Dec 2025 | +48.1% |
| FY Dec 2024 | +28.9% |
| FY Dec 2023 | -60.0% |
| FY Dec 2022 | -19.8% |
| FY Dec 2021 | -34.1% |
| Jun 2026 | -39.3% |
| Mar 2026 | -49.1% |
| Dec 2025 | +48.1% |
| Sep 2025 | +31.8% |
| Jun 2025 | +28.5% |
| Mar 2025 | +40.5% |
| Dec 2024 | +28.9% |
| Sep 2024 | -0.8% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing CYH
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $12.5B | $12.6B | $12.5B | $12.2B |
| Operating income | $1.5B | $542.0M | $957.0M | $821.0M |
| Net income | $509.0M | -$516.0M | -$133.0M | $46.0M |
| EPS (diluted) | 3.77 | -3.90 | -1.02 | 0.35 |
| Operating cash flow | $543.0M | $480.0M | $210.0M | $300.0M |
| Cash | $260.0M | $37.0M | $38.0M | $118.0M |
| Long-term debt | $10.4B | $11.4B | $11.5B | $11.6B |
SEC XBRL, fiscal years, as known on 2026-10-27
CYH Stock Sonar score 6/7 axes
Find similar shapesCompareCYH ranks highest on profitability (68th percentile) and financial health (37th), and lowest on risk and compliance (22nd), among Healthcare Services peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CYH filings, in plain words
Are Community Health Systems insiders buying or selling CYH?
In the 180 days to 2026-10-27, Community Health Systems insiders were net sellers, a net $118.4K across purchases and sales reported on Form 4, by 1 seller.
Are there planned insider sales of CYH?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $120.0K of stock; the latest, by William Norris Jennings, was filed 2026-08-25.
Read the full summary
In the 180 days to 2026-10-27, Community Health Systems insiders were net sellers of CYH, a net $118.4K across purchases and sales reported on Form 4 by 1 seller. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $120.0K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
